Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuoyan Tan

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
ACS Chemical Neuroscience|November 2, 2024
LRRK2 Inhibitors as Promising Treatment for Parkinson's DiseaseShuoyan Tan, Huanxiang Liu, Xiaojun Yao
ACS Chemical Neuroscience|August 13, 2021
Virtual Screening and Biological Activity Evaluation of New Potent Inhibitors Targeting LRRK2 Kinase DomainShuoyan Tan, Xiaoqing Gong, Huanxiang Liu, et al.
Physical Chemistry Chemical Physics : PCCP|July 10, 2024
Identification of novel LRRK2 inhibitors by structure-based virtual screening and alchemical free energy calculationShuoyan Tan, Xiaoqing Gong, Huanxiang Liu, et al.
International Journal of Molecular Sciences|September 9, 2022
Binding Thermodynamics and Dissociation Kinetics Analysis Uncover the Key Structural Motifs of Phenoxyphenol Derivatives as the Direct InhA Inhibitors and the Hotspot Residues of InhAQianqian Zhang, Jianting Han, Yongchang Zhu, et al.
Briefings in Bioinformatics|August 12, 2020
MolAICal: a soft tool for 3D drug design of protein targets by artificial intelligence and classical algorithmQifeng Bai, Shuoyan Tan, Tingyang Xu, et al.
Drug Discovery Today|August 6, 2025
Development of LRRK2 inhibitors through computational strategies: a promising avenue for Parkinson's diseaseXiaoqing Gong, Shuoyan Tan, Yuwei Yang, et al.
ACS Chemical Neuroscience|February 21, 2022
Molecular Modeling Study on the Interaction Mechanism between the LRRK2 G2019S Mutant and Type I Inhibitors by Integrating Molecular Dynamics Simulation, Binding Free Energy Calculations, and Pharmacophore ModelingShuoyan Tan, Qianqian Zhang, Jun Wang, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2020
Probing the Molecular Mechanism of Rifampin Resistance Caused by the Point Mutations S456L and D441V on Mycobacterium tuberculosis RNA Polymerase through Gaussian Accelerated Molecular Dynamics SimulationQianqian Zhang, Shuoyan Tan, Tong Xiao, et al.
Chinese Medicine|April 1, 2026
TCMNet: an AI-driven strategy for optimizing traditional Chinese medicineShuoyan Tan, Xin Shao, Xuting Zhang, et al.
ACS Chemical Neuroscience|October 31, 2019
Disclosing the Mechanism of Spontaneous Aggregation and Template-Induced Misfolding of the Key Hexapeptide (PHF6) of Tau Protein Based on Molecular Dynamics SimulationHongli Liu, Haiyang Zhong, Xuewei Liu, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
ACS Chemical Neuroscience|November 2, 2024
LRRK2 Inhibitors as Promising Treatment for Parkinson's DiseaseShuoyan Tan, Huanxiang Liu, Xiaojun Yao
ACS Chemical Neuroscience|August 13, 2021
Virtual Screening and Biological Activity Evaluation of New Potent Inhibitors Targeting LRRK2 Kinase DomainShuoyan Tan, Xiaoqing Gong, Huanxiang Liu, et al.
Physical Chemistry Chemical Physics : PCCP|July 10, 2024
Identification of novel LRRK2 inhibitors by structure-based virtual screening and alchemical free energy calculationShuoyan Tan, Xiaoqing Gong, Huanxiang Liu, et al.
International Journal of Molecular Sciences|September 9, 2022
Binding Thermodynamics and Dissociation Kinetics Analysis Uncover the Key Structural Motifs of Phenoxyphenol Derivatives as the Direct InhA Inhibitors and the Hotspot Residues of InhAQianqian Zhang, Jianting Han, Yongchang Zhu, et al.
Briefings in Bioinformatics|August 12, 2020
MolAICal: a soft tool for 3D drug design of protein targets by artificial intelligence and classical algorithmQifeng Bai, Shuoyan Tan, Tingyang Xu, et al.
Drug Discovery Today|August 6, 2025
Development of LRRK2 inhibitors through computational strategies: a promising avenue for Parkinson's diseaseXiaoqing Gong, Shuoyan Tan, Yuwei Yang, et al.
ACS Chemical Neuroscience|February 21, 2022
Molecular Modeling Study on the Interaction Mechanism between the LRRK2 G2019S Mutant and Type I Inhibitors by Integrating Molecular Dynamics Simulation, Binding Free Energy Calculations, and Pharmacophore ModelingShuoyan Tan, Qianqian Zhang, Jun Wang, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2020
Probing the Molecular Mechanism of Rifampin Resistance Caused by the Point Mutations S456L and D441V on Mycobacterium tuberculosis RNA Polymerase through Gaussian Accelerated Molecular Dynamics SimulationQianqian Zhang, Shuoyan Tan, Tong Xiao, et al.
Chinese Medicine|April 1, 2026
TCMNet: an AI-driven strategy for optimizing traditional Chinese medicineShuoyan Tan, Xin Shao, Xuting Zhang, et al.
ACS Chemical Neuroscience|October 31, 2019
Disclosing the Mechanism of Spontaneous Aggregation and Template-Induced Misfolding of the Key Hexapeptide (PHF6) of Tau Protein Based on Molecular Dynamics SimulationHongli Liu, Haiyang Zhong, Xuewei Liu, et al.
Pageof 2